$971 Million is the total value of Iron Triangle Partners LP's 26 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 90.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HUM | New | HUMANA INC | $80,359,000 | – | 181,512 | +100.0% | 8.28% | – |
| CTLT | New | CATALENT INC | $65,783,000 | – | 608,429 | +100.0% | 6.78% | – |
| MOH | Buy | MOLINA HEALTHCARE INC | $60,029,000 | +28.4% | 237,213 | +18.6% | 6.18% | +4.0% |
| ABBV | Buy | ABBVIE INC | $59,983,000 | +84.8% | 532,523 | +77.5% | 6.18% | +49.7% |
| WAT | New | WATERS CORP | $58,753,000 | – | 169,999 | +100.0% | 6.05% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $57,923,000 | +25.9% | 618,573 | +23.7% | 5.97% | +2.0% |
| CRL | Buy | CHARLES RIV LABS INTL INC | $54,722,000 | +34.9% | 147,928 | +5.7% | 5.64% | +9.3% |
| ISRG | New | INTUITIVE SURGICAL INC | $50,579,000 | – | 54,999 | +100.0% | 5.21% | – |
| NVRO | Buy | NEVRO CORP | $46,856,000 | +86.6% | 282,620 | +57.0% | 4.83% | +51.1% |
| GH | Buy | GUARDANT HEALTH INC | $43,467,000 | +184.7% | 350,000 | +250.0% | 4.48% | +130.7% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $34,139,000 | +9.5% | 976,245 | +4.3% | 3.52% | -11.3% |
| THC | New | TENET HEALTHCARE CORP | $32,423,000 | – | 484,005 | +100.0% | 3.34% | – |
| IDXX | Buy | IDEXX LABS INC | $31,578,000 | +84.4% | 50,000 | +42.9% | 3.25% | +49.4% |
| OSH | Buy | OAK STR HEALTH INC | $31,366,000 | +65.1% | 535,528 | +53.0% | 3.23% | +33.8% |
| CNMD | Buy | CONMED CORP | $29,850,000 | +14.3% | 217,204 | +8.6% | 3.08% | -7.4% |
| ICLR | New | ICON PLC | $17,570,000 | – | 85,000 | +100.0% | 1.81% | – |
| CANO | New | CANO HEALTH INC | $10,890,000 | – | 900,000 | +100.0% | 1.12% | – |
| STXS | New | STEREOTAXIS INC | $1,860,000 | – | 192,928 | +100.0% | 0.19% | – |
| OLK | New | OLINK HLDG ABsponsored ads | $861,000 | – | 25,000 | +100.0% | 0.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.